title: Side effects and good effects from new chemotherapeutic agents. Case 1. Gefitinib-induced interstitial fibrosis.
authors.affiliation: Department of Veterans Affairs VA, University of Medicine and Dentistry of New Jersey--New Jersey Medical School, New Jersey Health Care System, East Oranage, USA.
authors.forename: Neil C
authors.initials: NC
authors.lastname: Nagaria
authors.forename: Janet
authors.initials: J
authors.lastname: Cogswell
authors.forename: Jin K
authors.initials: JK
authors.lastname: Choe
authors.forename: Basil
authors.initials: B
authors.lastname: Kasimis
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003371:Cough / Q000209:etiology; D004417:Dyspnea / Q000209:etiology; D017809:Fatal Outcome; D000077156:Gefitinib; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib